COGT
Price
$36.30
Change
+$0.46 (+1.28%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
6.2B
49 days until earnings call
Intraday BUY SELL Signals
DMRA
Price
$22.87
Change
-$1.02 (-4.27%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
1.41B
43 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

COGT vs DMRA

COGT vs DMRA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
COGT vs. DMRA commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COGT is a Buy and DMRA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (COGT: $35.83 vs. DMRA: $23.84)
Brand notoriety: COGT and DMRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: COGT: 159% vs. DMRA: 144%
Market capitalization -- COGT: $6.12B vs. DMRA: $1.47B
COGT [@Biotechnology] is valued at $6.12B. DMRA’s [@Biotechnology] market capitalization is $1.47B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COGT’s FA Score shows that 1 FA rating(s) are green whileDMRA’s FA Score has 1 green FA rating(s).

  • COGT’s FA Score: 1 green, 4 red.
  • DMRA’s FA Score: 1 green, 4 red.
According to our system of comparison, DMRA is a better buy in the long-term than COGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COGT’s TA Score shows that 5 TA indicator(s) are bullish while DMRA’s TA Score has 5 bullish TA indicator(s).

  • COGT’s TA Score: 5 bullish, 4 bearish.
  • DMRA’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both COGT and DMRA are a good buy in the short-term.

Price Growth

COGT (@Biotechnology) experienced а +8.00% price change this week, while DMRA (@Biotechnology) price change was +18.78% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

Reported Earning Dates

COGT is expected to report earnings on Aug 11, 2026.

DMRA is expected to report earnings on Aug 05, 2026.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COGT($6.2B) has a higher market cap than DMRA($1.41B). DMRA YTD gains are higher at: 3.607 vs. COGT (0.859). DMRA has higher annual earnings (EBITDA): -238.99M vs. COGT (-345.43M). COGT has more cash in the bank: 866M vs. DMRA (533M). COGT (0) and DMRA (0) have equivalent revenues.
COGTDMRACOGT / DMRA
Capitalization6.2B1.41B439%
EBITDA-345.43M-238.99M145%
Gain YTD0.8593.60724%
P/E RatioN/AN/A-
Revenue00-
Total Cash866M533M162%
Total Debt239MN/A-
FUNDAMENTALS RATINGS
COGT: Fundamental Ratings
COGT
OUTLOOK RATING
1..100
31
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
22
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
COGTDMRA
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
77%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 7 days ago
85%
Declines
ODDS (%)
Bearish Trend 21 days ago
80%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
COGT
Daily Signal:
Gain/Loss:
DMRA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XLKI27.630.10
+0.35%
State Street®TechSelSectSPDR®PrmETF
IJR143.260.05
+0.03%
iShares Core S&P Small-Cap ETF
NUKZ71.09-0.36
-0.50%
Range Nuclear Renaissance ETF
COPJ41.52-0.98
-2.31%
Sprott Junior Copper Miners ETF
WANT40.76-2.28
-5.30%
Direxion Daily Cnsmr Discret Bull 3X ETF

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with ENGN. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then ENGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
+3.72%
ENGN - COGT
47%
Loosely correlated
-1.45%
DMRA - COGT
46%
Loosely correlated
+12.29%
REPL - COGT
42%
Loosely correlated
+9.67%
QCLS - COGT
39%
Loosely correlated
-0.75%
RZLT - COGT
38%
Loosely correlated
+2.59%
More

DMRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, DMRA has been loosely correlated with COGT. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if DMRA jumps, then COGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DMRA
1D Price
Change %
DMRA100%
+12.29%
COGT - DMRA
46%
Loosely correlated
+3.72%
NERV - DMRA
45%
Loosely correlated
+4.47%
INBX - DMRA
44%
Loosely correlated
+0.54%
RANI - DMRA
44%
Loosely correlated
-1.07%
GNTA - DMRA
38%
Loosely correlated
+14.88%
More